Consolidated Statements of Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 25, 2022	Dec. 26, 2021	Dec. 25, 2022	Dec. 26, 2021
Consolidated Statements of Income (Loss)
Revenues	$ 114,879,700	$ 102,462,400	$ 347,863,800	$ 315,954,700
Cost of goods sold	91,188,600	82,841,600	277,614,400	256,852,000
Gross profit	23,691,100	19,620,800	70,249,400	59,102,700
Selling, general and administrative expenses	22,715,800	19,403,800	67,846,300	62,038,600
Operating income (loss)	975,300	217,000	2,403,100	(2,935,900)
Interest expense, net	516,400	131,000	1,159,200	503,400
Income (loss) from continuing operations before income taxes	458,900	86,000	1,243,900	(3,439,300)
Provision for (benefit from) income taxes	34,200	(1,129,000)	(46,600)	(1,166,200)
Net income (loss) from continuing operations	424,700	1,215,000	1,290,500	(2,273,100)
Income (loss) from discontinued operations, net of taxes		243,800		1,187,900
Net income (loss)	$ 424,700	$ 1,458,800	$ 1,290,500	$ (1,085,200)
Basic income (loss) per share
Continuing operations (in dollars per share)	$ 0.05	$ 0.14	$ 0.14	$ (0.26)
Discontinued operations (in dollars per share)		0.03		0.13
Consolidated operations (in dollars per share)	0.05	0.16	0.14	(0.12)
Diluted income (loss) income per share
Continuing operations (in dollars per share)	0.05	0.14	0.14	(0.26)
Discontinued operations (in dollars per share)		0.03		0.13
Consolidated operations (in dollars per share)	$ 0.05	$ 0.16	$ 0.14	$ (0.12)
Basic weighted-average common shares outstanding (in shares)	9,199,494	8,957,502	9,138,889	8,910,857
Effect of dilutive options and other equity instruments (in shares)	17,654	39,335	49,106
Diluted weighted-average common shares outstanding (in shares)	9,217,148	8,996,837	9,187,995	8,910,857